$GATO
Gatos Silver, Inc.

2023 Q1 Form 10-Q Financial Statement

#000110465923075378 Filed on June 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.540M $8.500M $6.780M
YoY Change -18.29% 130.35% 88.33%
% of Gross Profit
Research & Development $30.00K $0.00 $110.0K
YoY Change -72.73% -100.0% -50.0%
% of Gross Profit
Depreciation & Amortization $40.00K $50.00K $40.00K
YoY Change 0.0% 25.0% 300.0%
% of Gross Profit
Operating Expenses $5.600M $8.550M $6.930M
YoY Change -19.19% 114.29% 80.94%
Operating Profit
YoY Change
Interest Expense $4.850M $12.62M $6.730M
YoY Change -27.93% -36.99% 149.26%
% of Operating Profit
Other Income/Expense, Net $1.423M $1.620M $1.146M
YoY Change 24.17% 1.89% -333.88%
Pretax Income $840.0K -$2.210M $1.050M
YoY Change -20.0% -96.48% -164.81%
Income Tax $0.00 $1.570M
% Of Pretax Income 0.0%
Net Earnings $835.0K -$3.770M $18.83M
YoY Change -95.57% -93.99% -1262.28%
Net Earnings / Revenue
Basic Earnings Per Share $0.01 $0.27
Diluted Earnings Per Share $0.01 -$0.05 $0.27
COMMON SHARES
Basic Shares Outstanding 69.16M 69.16M
Diluted Shares Outstanding 69.31M 69.31M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.90M $17.00M $5.300M
YoY Change 143.4% 157.58% -82.9%
Cash & Equivalents $12.90M $17.00M $5.284M
Short-Term Investments
Other Short-Term Assets $16.37M $16.87M $2.850M
YoY Change 474.25% 374.17% -13.64%
Inventory
Prepaid Expenses $2.359M $2.890M $2.219M
Receivables
Other Receivables
Total Short-Term Assets $29.94M $35.65M $8.764M
YoY Change 241.58% 202.97% -77.87%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $352.8M $347.8M $379.8M
YoY Change -7.11% 4.32% 67.98%
Other Assets $50.00K $60.00K $28.00K
YoY Change 78.57% 71.43% -72.0%
Total Long-Term Assets $352.9M $347.9M $379.8M
YoY Change -7.1% -2.11% 68.0%
TOTAL ASSETS
Total Short-Term Assets $29.94M $35.65M $8.764M
Total Long-Term Assets $352.9M $347.9M $379.8M
Total Assets $382.8M $383.5M $388.6M
YoY Change -1.49% 4.46% 46.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $455.0K $586.0K $330.0K
YoY Change 37.88% 198.98% 10.0%
Accrued Expenses $1.404M $2.761M $1.129M
YoY Change 24.36% 343.18% -62.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.00M $26.40M $2.600M
YoY Change 823.08% 1785.71% -25.71%
LONG-TERM LIABILITIES
Long-Term Debt $8.700M $8.700M $12.70M
YoY Change -31.5% -30.95%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $8.700M $8.700M $12.70M
YoY Change -31.5% -30.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.00M $26.40M $2.600M
Total Long-Term Liabilities $8.700M $8.700M $12.70M
Total Liabilities $32.70M $35.00M $15.20M
YoY Change 115.13% 150.0% 334.29%
SHAREHOLDERS EQUITY
Retained Earnings -$197.9M -$198.7M -$172.0M
YoY Change 15.04% 4.13%
Common Stock $117.0K $117.0K $117.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $350.1M $348.5M $373.4M
YoY Change
Total Liabilities & Shareholders Equity $382.8M $383.5M $388.6M
YoY Change -1.49% 4.46% 46.26%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income $835.0K -$3.770M $18.83M
YoY Change -95.57% -93.99% -1262.28%
Depreciation, Depletion And Amortization $40.00K $50.00K $40.00K
YoY Change 0.0% 25.0% 300.0%
Cash From Operating Activities -$4.103M $5.870M -$1.332M
YoY Change 208.03% -197.83% -79.79%
INVESTING ACTIVITIES
Capital Expenditures $30.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$30.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -4.110M 0.000
YoY Change -2155.0% -100.0%
NET CHANGE
Cash From Operating Activities -4.103M 5.870M -1.332M
Cash From Investing Activities 0.000 -30.00K 0.000
Cash From Financing Activities 0.000 -4.110M 0.000
Net Change In Cash -4.103M 1.730M -1.332M
YoY Change 208.03% -129.83% -98.88%
FREE CASH FLOW
Cash From Operating Activities -$4.103M $5.870M -$1.332M
Capital Expenditures $30.00K
Free Cash Flow $5.840M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001517006
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39649
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
GATOS SILVER, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2654848
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
925 W Georgia Street, Suite 910
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2023Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3L2
CY2023Q1 dei City Area Code
CityAreaCode
604
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
424-0984
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
GATO
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69162223
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12901000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17004000
CY2023Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
669000
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1773000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
16366000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
16871000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
29936000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
35648000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
352844000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
347793000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
60000
CY2023Q1 us-gaap Assets
Assets
382830000
CY2022Q4 us-gaap Assets
Assets
383501000
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
24041000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
26358000
CY2023Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
8689000
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
8661000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
117000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
117000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
547897000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
547114000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-197914000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198749000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
350100000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
348482000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
382830000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
383501000
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
26000
CY2022Q1 us-gaap Exploration Expense
ExplorationExpense
110000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5536000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6777000
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
37000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
5599000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
6931000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5011000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6835000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1423000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1146000
CY2023Q1 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
6434000
CY2022Q1 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
7981000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
835000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
348482000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
783000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
835000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
350100000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
331222000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1482000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
333754000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
835000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1050000
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
37000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
743000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1588000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
64000
CY2023Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
5011000
CY2022Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
6835000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1104000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-962000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2289000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1087000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-478000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-708000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4103000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1332000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4103000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1332000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17004000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6616000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12901000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5284000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
173000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
102000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2890000
CY2023Q1 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
13100000
CY2022Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
13100000
CY2023Q1 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
786000
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
730000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2359000
CY2023Q1 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
121000
CY2022Q4 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
151000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
16366000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
16871000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
95000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
455000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
586000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1404000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2761000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1087000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1889000
CY2023Q1 gato Litigation Settlement Liability Current
LitigationSettlementLiabilityCurrent
21000000
CY2022Q4 gato Litigation Settlement Liability Current
LitigationSettlementLiabilityCurrent
21000000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
95000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122000
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
24041000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
26358000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
743000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1588000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
835000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
146796
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
146796
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q4 gato Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
50000000
CY2023Q1 gato Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
25000000
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
26000
CY2022Q1 us-gaap Exploration Expense
ExplorationExpense
110000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5536000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6777000
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
37000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5011000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6835000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1423000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1146000
CY2023Q1 us-gaap Assets
Assets
382830000
CY2022Q1 us-gaap Assets
Assets
348968000
CY2022Q4 gato Litigation Settlement Liability Current
LitigationSettlementLiabilityCurrent
21000000
CY2022Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
13100000

Files In Submission

Name View Source Status
0001104659-23-075378-index-headers.html Edgar Link pending
0001104659-23-075378-index.html Edgar Link pending
0001104659-23-075378.txt Edgar Link pending
0001104659-23-075378-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gato-20230331.xsd Edgar Link pending
gato-20230331x10q.htm Edgar Link pending
gato-20230331x10q003.jpg Edgar Link pending
gato-20230331xex31d1.htm Edgar Link pending
gato-20230331xex31d2.htm Edgar Link pending
gato-20230331xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
gato-20230331_cal.xml Edgar Link unprocessable
gato-20230331_def.xml Edgar Link unprocessable
gato-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gato-20230331_pre.xml Edgar Link unprocessable
gato-20230331x10q_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending